These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 12269713)

  • 21. Increased regulation of medication compounding by state boards of pharmacy.
    Reynolds KA; Ibrahim SA; Hellquist KA; Poon E; Alam M
    Arch Dermatol Res; 2022 Oct; 314(8):787-790. PubMed ID: 34698896
    [TBL] [Abstract][Full Text] [Related]  

  • 22. FDA states policy on pharmacy compounding. Agency follows up on supreme court ruling.
    Young D
    Am J Health Syst Pharm; 2002 Jul; 59(13):1222, 1224. PubMed ID: 12116887
    [No Abstract]   [Full Text] [Related]  

  • 23. Deficiencies of product labeling directions for the preparation of radiopharmaceuticals.
    Hung JC; Ponto JA; Gadient KR; Frie JA; Aksamit CM; Enquist CL; Carrels KE
    J Am Pharm Assoc (2003); 2004; 44(1):30-5. PubMed ID: 14965150
    [TBL] [Abstract][Full Text] [Related]  

  • 24. AMCP Partnership Forum: FDAMA Section 114-Improving the Exchange of Health Care Economic Data.
    J Manag Care Spec Pharm; 2016 Jul; 22(7):826-31. PubMed ID: 27333323
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Food and Drug Administration requirements for testing and approval of new radiopharmaceuticals.
    Harapanhalli RS
    Semin Nucl Med; 2010 Sep; 40(5):364-84. PubMed ID: 20674596
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A pharmacist-driven Food and Drug Administration incident surveillance and response program for compounded drugs.
    Janusziewicz AN; Glueck SN; Park SY; Nguyen DN; Rimmel SC; Cascio LA; Doh GY; Martin-Yeboah GF
    Am J Health Syst Pharm; 2021 Jul; 78(15):1438-1443. PubMed ID: 33889929
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Regulation of compounding by the food and drug administration: a tale of 2 circuits.
    Williams KG
    J Pharm Pract; 2010 Oct; 23(5):502-6. PubMed ID: 21507854
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Strengthening radiopharmacy practice in IAEA Member States.
    Duatti A; Bhonsle U
    Semin Nucl Med; 2013 May; 43(3):188-94. PubMed ID: 23561456
    [TBL] [Abstract][Full Text] [Related]  

  • 29. FDA, states discuss pharmacy compounding regulatory framework.
    Traynor K
    Am J Health Syst Pharm; 2013 Feb; 70(3):180, 182. PubMed ID: 23327976
    [No Abstract]   [Full Text] [Related]  

  • 30. Sterile compounding: clinical, legal, and regulatory implications for patient safety.
    Qureshi N; Wesolowicz L; Stievater T; Lin AT
    J Manag Care Spec Pharm; 2014 Dec; 20(12):1183-91. PubMed ID: 25443512
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Basics of Sterile Compounding. Quality Assurance and Quality Control: Being Prepared for U.S. Food and Drug Administration Inspections and Staying in Compliance with United States Pharmacopeia Chapter <797>: Part 2.
    Martin M
    Int J Pharm Compd; 2018; 22(6):475-478. PubMed ID: 30384348
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Performance Improvement in 503A Compounding Pharmacies: A PLAN FOR ASSESSMENT, IMPLEMENTATION, AND SUSTAINED SUCCESS.
    Pritchett J; Mixon W; O'Connell K
    Int J Pharm Compd; 2016; 20(1):29-36. PubMed ID: 27125054
    [TBL] [Abstract][Full Text] [Related]  

  • 33. From the SNM Committee on Pharmacopeia: Exemption of radiopharmaceuticals from <797>.
    Hung JC;
    J Nucl Med; 2004 Oct; 45(10):13N, 16N. PubMed ID: 15551509
    [No Abstract]   [Full Text] [Related]  

  • 34. Basics of compounding: implementing United States pharmacopeia chapter <795> pharmaceutical compounding--nonsterile preparations, part 4.
    Allen LV
    Int J Pharm Compd; 2012; 16(1):64-8. PubMed ID: 23050315
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmaceutical compounding or pharmaceutical manufacturing? A regulatory perspective.
    Timko RJ; Crooker PE
    Int J Pharm Compd; 2014; 18(2):101-11. PubMed ID: 24881112
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An overview of United States pharmacopeia chapter 795 and american society of health-system pharmacists guidelines for nonsterile compounding.
    McElhiney LF
    Int J Pharm Compd; 2009; 13(6):525-30. PubMed ID: 23965326
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Update on medical and regulatory issues pertaining to compounded and FDA-approved drugs, including hormone therapy.
    Pinkerton JV; Pickar JH
    Menopause; 2016 Feb; 23(2):215-23. PubMed ID: 26418479
    [TBL] [Abstract][Full Text] [Related]  

  • 38. USP General Chapter <825> Impact on Nuclear Medicine Technology Practice.
    Hinkle GH
    J Nucl Med Technol; 2020 Jun; 48(2):106-113. PubMed ID: 32499321
    [TBL] [Abstract][Full Text] [Related]  

  • 39. USP general chapter <797> pharmaceutical compounding-sterile preparations.
    Hung JC
    J Nucl Med; 2004 Jun; 45(6):20N, 28N. PubMed ID: 15181114
    [No Abstract]   [Full Text] [Related]  

  • 40. Pharmacy compounding: background on the latest federal initiatives.
    Nichols D
    J Nucl Med; 1998 Jan; 39(1):26N. PubMed ID: 9443726
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.